A one-minute look at managed care news during the week of April 27, 2015, including more good news for the much-anticipated PCSK9 inhibitors and growth in the individual insurance market enrollment.
This week, a meta-analysis in JAMA confirmed that the PCSK9 inhibitors dramatically reduce low-density lipoprotein as well as all-cause mortality and cardiovascular mortality. However, an accompanying editorial cautioned against too much enthusiasm.
A new report from the Kaiser Family Foundation found that enrollment in the individual insurance market grew in 2014 after the first open enrollment period of the Affordable Care Act. Enrollment is expected to continue to grow in 2015, but at a slower pace.
The first videos from the Spring 2015 Oncology Stakeholders Summit is now available online here.